With shares of Netflix (NASDAQ:NFLX) trading around $382, is NFLX an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementNetflix is an Internet subscription service that streams television shows and movies. The company�� subscribers can watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices. In the United States, subscribers can also receive DVDs delivered to their homes. Netflix has revolutionized the television and movie industry with its services.
��t�� been a good year for Netflix,��wrote CEO Reed Hastings and CFO David Wells in a letter to shareholders. ��eople around the world want what we offer: consumer-in-control Internet television.��Today, this seems to be the understatement of the century.�As quick as an instant streaming download, Netflix shares skyrocketed more than 16 percent to around $388 in after hours trading — circling a high for the year — following the news the the video streaming phenomenon beat earnings expectations.�The company reported full year net income of $112.4 million, crushing the Street�� call for $103.4 million. Earnings per share were $1.85, also well ahead of the the Wall Street consensus estimate. At $4.4 billion full-year revenue was in line with expectations.�For the fourth-quarter, Netflix�� net income came in at $48.4 million, or 79 cents per share, beating the Streets $40.8 million and 66 cent estimates respectively. At $1.2 billion, revenue was also above expectations.
Top Canadian Stocks To Invest In 2015: Hercules Technology Growth Capital Inc (HTGC)
Hercules Technology Growth Capital, Inc. (HTGC), incorporated on December 18, 2003, is an internally managed, non-diversified closed-end investment company. The Company is a specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and clean-technology industries at all stages of development. The Company's investment objective is to maximize the Company's portfolio total return by generating current income from its debt investments and capital appreciation from its equity-related investments. The Company invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The Company also makes investments in qualifying small businesses through two wholly-owned, small business investment company (SBIC) subsidiaries, Hercules Technology II, L.P. (HT II) and Hercules Technology III, L.P. (HT III).
The Company focuses its investments in companies active in the technology industry sub-sectors characterized by products or services that requires advanced technologies, including, but not limited to, computer software and hardware, networking systems, semiconductors, semiconductor capital equipment, information technology infrastructure or services, Internet consumer and business services, telecommunications, telecommunications equipment, renewable or alternative energy, media and life science. Within the life science sub-sector, the Company generally focuses on medical devices, bio-pharmaceutical, drug discovery, drug delivery, health care services and information systems companies. Within the clean technology sub-sector, the Company focuses on sustainable and renewable energy technologies and energy efficiency and monitoring technologies. The Company refers to all of these companies as technology-related companies and intend, under normal circumstances, to invest at least 80% of the value of its assets in such businesses. Advisors' Opinion:
- [By Lawrence Meyers]
Business development companies like Hercules Technology Growth Capital (HTGC) invest money into middle-market companies that are experiencing fast growth.� Often, these investments take the form of mezzanine debt paying interest in the teens, and some warrants.� Hercules likes to focus more on senior secured revolvers and term loans to refinance existing debt, and will even take second-liens.� It has more attractive upside with its investments than other BDCs because it focuses on tech, energy tech, healthcare, life sciences and business services — all of which can fetch higher multiples upon exit.� It pays out a sturdy 7.3% dividend.
Hot Integrated Utility Stocks To Invest In 2014: iShares U.S. Oil & Gas Exploration & Production ETF (IEO)
iShares Dow Jones U.S. Oil & Gas Exploration & Production Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Oil Exploration & Production Index (the Index). The Index measures the performance of the oil exploration and production sub-sector of the United States equity market. The Index includes companies that are engaged in the exploration for and extraction, production, refining and supply of oil and gas products.
The Fund will concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. Since all of the securities included in the Index are issued by companies in the oil exploration and production sub-sector, the Fund will be concentrated in the exploration and production industry. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Michael Burnick]
The big E&P (exploration and production) and major integrated oil stocks see profits rise and fall with the price of crude. The iShares US Oil & Gas Exploration & Production ETF (IEO) is one way to play this part of the oil patch.
- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some gas and oil stocks to your portfolio, the iShares Dow Jones U.S. Oil and Gas Exploration Index ETF (NYSEMKT: IEO ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this gas and oil ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The gas and oil ETF's expense ratio -- its annual fee -- is a relatively low 0.47%. The fund is on the small side, too, so if you're thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in to this gas and oil ETF. - [By John Udovich]
At first glance, you might think it strange that we have both the ProShares UltraShort DJ-UBS Crude Oil ETF (NYSEARCA: SCO), a bearish bet on oil, and the iShares Dow Jones US Oil & Gas Ex Index ETF (NYSEARCA: IEO), a more bullish bet on both domestic oil and gas, in our SmallCap Network Elite Opportunity (SCN EO) portfolio. But there is a method to our apparent madness as one can be both bearish and bullish on oil and/or gas at the same time.
Hot Integrated Utility Stocks To Invest In 2014: Progress Energy Inc.(PGN)
Progress Energy, Inc., a utility holding company, engages in the generation, transmission, distribution, and sale of electricity in North Carolina, South Carolina, and Florida. It uses coal, oil, hydroelectric, natural gas, and nuclear power to generate electricity. The company also engages in various alternative energy projects to generate electricity from swine waste and other plant or animal sources, biomass, solar, hydrogen, and landfill-gas technologies. Progress Energy serves various industries, including chemicals, textiles, paper, food, metals, wood products, rubber and plastics, and stone products, as well as phosphate rock mining and processing, electronics design and manufacturing, and citrus and other food processing. It has approximately 22,000 megawatts of regulated electric generation capacity and serves approximately 3.1 million retail electric customers, as well as other load-serving entities. The company was formerly known as CP&L Energy, Inc. Progress En ergy, Inc. was founded in 1925 and is headquartered in Raleigh, North Carolina.
Advisors' Opinion:- [By Holly LaFon] ess Energy shares climbed over 2011 as the company announced in January it would merge with Duke Energy. Together, they will form the nation�� largest utility with a combined enterprise value of $65 billion and $37 billion in market cap. The new company will have 57 gigawatts of domestic generating capacity through a mix of coal, nuclear, natural gas, oil and renewable resources. Progress energy shareholders will receive an approximately 3 percent dividend increase.
Incidentally, development of a comprehensive energy policy was one of what Grantham called ��he most important and most dangerous issues��facing the world.
Progress is at the forefront of the push for nuclear energy in the U.S., which has been deemed the ��uclear renaissance.��Thirty-five percent of the electricity used by Progress Energy customers comes from one of their four nuclear sites, two in North Carolina, and one each in South Carolina and Florida. It plans to build another reactor in Levy County, Florida.
Revenue at Progress Energy has declined at a 2.6% annual rate over the past five years, and it achieved cash flow of $95 million in 2010, after three years of losses. Earnings have remained positive, reaching a record for the decade of $856 million in 2010.
RSC Holdings (RRR)
RSC is a machinery rental service for construction, industrial, petrochemical, governmental and manufacturing businesses in the U.S. and Canada. RSC tends to benefit in economic downturns, as more businesses turn to renting rather than buying equipment to cut costs. Rented equipment rose 20.7% percent (the sixth consecutive quarter of double-digit growth) and rental revenue increased 27% in the fourth quarter of 2011, compared to last year.
United Rentals (URI), one of RSC�� largest competitors, had a rental revenue increase of 18.5% in the fourth quarter compared to last year, which included a 6.7% increase in rental rates.
The company�� fleet utilization also
Hot Integrated Utility Stocks To Invest In 2014: Heico Corporation (HEI)
HEICO Corporation, through its subsidiaries, designs, manufactures, and sells aerospace, defense, and electronic related products and services in the United States and internationally. The company�s Flight Support Group segment provides jet engine and aircraft component replacement parts; thermal insulation blankets and parts; and specialty components for aerospace and industrial original equipment manufacturers, and the United States government. This segment also distributes hydraulic, pneumatic, mechanical, and electro-mechanical components for the commercial, regional, and general aviation markets; and offers repair and overhaul services for jet engine and aircraft component parts, avionics, instruments, composites, and flight surfaces of commercial airlines, as well as for avionics and navigation systems, subcomponents, and other instruments utilized on military aircrafts. Its Electronic Technologies Group segment provides a range of electronic, microwave, and electro -optical products, including infrared simulation and test equipment, laser rangefinder receivers, electrical and back-up power supplies, power conversion products, underwater locator beacons, electromagnetic and radio frequency interference shielding, capacitor charging power supplies, amplifiers, traveling wave tube amplifiers, photo detectors, amplifier modules, and microwave power modules. This segment also offers flash lamp and laser diode drivers, arc lamp power supplies, cable assemblies, high voltage power supplies, high voltage interconnection devices and wires, high voltage energy generators, and high frequency power delivery systems. Its products link devices, such as telemetry receivers, digital cameras, high resolution scanners, simulation systems, and test systems to computer for the U.S. and foreign military agencies, prime defense contractors, and commercial and defense satellite and spacecraft manufacturers. The company was founded in 1949 and is headquartere d in Hollywood, Florida.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, jet engine replacement parts manufacturer HEICO (NYSE: HEI ) has earned a coveted five-star ranking.
Hot Integrated Utility Stocks To Invest In 2014: Onconova Therapeutics Inc (ONTX)
Onconova Therapeutics, Inc. (Onconova), incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways, which promote cancer. It has three clinical-stage product candidates and six preclinical programs. Its preclinical pipeline includes six programs, which target kinases, cellular metabolism or division.
Rigosertib
Rigosertib, the Company�� product candidate, is being tested in a range of ongoing Phase-II and Phase-III clinical trials. The Company is conducting a pivotal phase-III trial of rigosertib under a Special Protocol Assessment (SPA), from the United States Food and Drug Administration (FDA), for higher risk myelodysplastic syndromes (MDS). The Company is also evaluating rigosertib in a Phase-III trial for metastatic pancreatic cancer, in two Phase-II trials for transfusion-dependent lower risk MDS, and in a Phase-II trial for head and neck cancers. Rigosertib has been granted orphan drug status for MDS in both the United States and Europe, as well as orphan drug status for pancreatic cancer in the United States. Baxter Healthcare SA (Baxter), a subsidiary of Baxter International Inc., has commercialization rights for rigosertib in Europe and SymBio Pharmaceuticals Limited (SymBio), has commercialization rights in Japan and Korea. Rigosertib is an inhibitor of two cellular signaling pathways: phosphoinositide 3-kinase (PI3K), and polo-like kinase (PLK), both of which are frequently over-active in cancer cells. By inhibiting the PI3K pathway in cancer cells, rigosertib promotes tumor cell apoptosis, or programmed cell death. It is testing both intravenous and oral formulations of rigosertib, referred to as rigosertib IV and rigosertib Oral, in clinical trials.
ON 013105
The Company�� clinical-stage product candidate, ON 013105, is i! n a Phase I trial in patients with relapsed or refractory lymphoma, including an aggressive form of non-Hodgkin's lymphoma identified as mantle cell lymphoma (MCL), and acute lymphoid leukemia (ALL). ON 013105 suppresses the accumulation of cyclin D1 in cancer cells.
Recilisib
The Company�� clinical-stage product candidate, recilisib, is being developed in collaboration with the United States Department of Defense (DoD), for acute radiation syndromes (ARS). The Company has completed four Phase-I trials to evaluate the safety and pharmacokinetics of recilisib in healthy human adult subjects using both subcutaneous and oral formulations, referred to as recilisib SC and recilisib Oral.
Preclinical Programs
The Company�� ON 1231320 is a specific inhibitor of Polo-like Kinase 2 (PLK2), and in preclinical studies, it induced mitotic arrest and reduced tumor burden in mice injected subcutaneously with colon tumor and triple-negative breast cancer cells. The Company�� ON 123300 inhibits the activity of two kinases, cyclin-dependent kinase 4 (CDK4), and AMP-activated protein kinase 5 (ARK5). Its ON 108600 is a dual inhibitor of two growth-regulatory kinases. Cyclin-dependent kinase 9 is over expressed in several cancers, including leukemias and lymphomas. Casein kinase 2 is overexpressed in a range of tumor types. ON 044580 inhibits mutant forms of the two target kinases, including Janus Kinase 2 (JAK2) and imatinib-resistant Bcr-Abl Kinase (Bcr-Abl). Its ON 24 compounds cause tubulin to depolymerize, inducing mitotic arrest in cultured tumor cell lines. Its ON 146040 inhibits the growth of a range of blood cancer cell lines, including Burkitt's lymphoma, MCL, multiple myeloma and chronic myeloid leukemia.
The Company competes with Eisai Inc., Celgene Corporation, Genentech, Inc., Cell Therapeutics, Inc., Cyclacel Pharmaceuticals, Inc., Telik, Inc., Spectrum Pharmaceuticals, Inc., Astex, Array BioPharma Inc., Astellas Pharma, Inc., Threshold! Pharmace! uticals, Inc., Pharmacyclics Inc., Soligenix, Inc., Cellerant Therapeutics, Inc. and Cleveland BioLabs, Inc.
Advisors' Opinion:- [By gurujx]
Onconova Therapeutics Inc (ONTX) Reached the 3-year Low of $4.18
The prices of Onconova Therapeutics Inc (ONTX) shares have declined to close to the 3-year low of $4.18, which is 86.8% off the 3-year high of $31.13.
- [By Roberto Pedone]
Onconova Therapeutics (ONTX), a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. This stock closed up 2.5% to $5.15 in Thursday's trading session.
Thursday's Range: $4.97-$5.19
52-Week Range: $4.10-$31.13
Thursday's Volume: 132,000
Three-Month Average Volume: 216,102From a technical perspective, ONTX trended modestly higher here with lighter-than-average volume. This stock has been uptrending over the last few weeks, with shares moving higher from its low of $4.10 to its recent high of $5.52. During that uptrend, shares of ONTX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ONTX within range of triggering a near-term breakout trade. That trade will hit if ONTX manages to take out Thursday's intraday high of $5.19 to some more key overhead resistance at $5.52 with high volume.
Traders should now look for long-biased trades in ONTX as long as it's trending above some near-term support levels at $4.80 or at $4.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 216,102 shares. If that breakout gets underway soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $5.83 to $6.27. Any high-volume move above those levels will then give ONTX a chance to tag $7.
Hot Integrated Utility Stocks To Invest In 2014: ONEOK Inc.(OKE)
ONEOK, Inc., a diversified energy company, operates as a natural gas distributor primarily in the United States. The company operates in three segments: ONEOK Partners, Distribution, and Energy Services. The ONEOK Partners segment engages in gathering, processing, fractionating, transporting, storing, and marketing natural gas and natural gas liquids (NGL) principally in the Mid-Continent and Rocky Mountain regions, which include Anadarko Basin of Oklahoma, Fort Worth Basin of Texas, Hugoton and Central Kansas Uplift Basins of Kansas, Williston Basin of Montana, and North Dakota and the Powder River Basin of Wyoming. This segment offers its services to oil and gas production companies; natural gas gathering and processing companies; petrochemical, refining, and NGL marketing companies; Local distribution companies (LDCs) and power generating companies; and natural gas marketing and NGL gathering companies, and propane distributors. The Distribution segment provides natural gas distribution services to residential, commercial, industrial, and transportation customers, as well as public authority customers, such as cities, governmental agencies, and schools in Oklahoma, Kansas, and Texas. The Energy Services segment delivers physical natural gas products and risk management services through its network of contracted transportation and storage capacity, and natural gas supply. This segment?s customers primarily comprise LDCs, electric utilities, and industrial end users. The company was founded in 1906 and is headquartered in Tulsa, Oklahoma.
Advisors' Opinion:- [By David Dittman]
Question: Do you think ONEOK Inc (NYSE: OKE) will go much higher? I bought it at $45.05
Answer: ONEOK is running wild in anticipation of its completion of transactions that will make it essentially a general partner, with interests in ONEOK Partners LP (NYSE: OKS) and the soon-to-be-spun-out ONE Gas Inc (NYSE: OGS). ONEOK already has an admirable record of dividend growth, and these moves will drive acceleration in 2014 payout growth.
No comments:
Post a Comment